The TRIM29 protein is the product of the ataxia telangiectasia group D complementation (ATDC) gene, which has been found to be associated with a variety of biological processes, such as tumor progression and transduction of DNA damage signal. The gene discussed is TRIM29; the disease is neoplasm.